Ilsung Pharm Net Asset Quality Index
Ilsung Pharm net asset quality index. Ilsung Pharm (003120) has a Net Asset Quality Index of 96.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩394.04 Billion minus total liabilities of ₩14.27 Billion yields net assets of ₩379.77 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Ilsung Pharm net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Ilsung Pharm (2013–2025)
Net asset quality index of Ilsung Pharm from 2013 to 2025. This chart shows how Ilsung Pharm's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 96.4%, representing net assets of ₩379.77 Billion against total assets of ₩394.04 Billion KRW. Check how strategically is Ilsung Pharm's equity deployed to assess the company's strategic physical and investment asset allocation.
Ilsung Pharm Net Asset Quality Index by Year (2013–2025)
Ilsung Pharm net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Ilsung Pharm from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Ilsung Pharm stock valuation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.9% | ₩386.34 Billion | ₩403.01 Billion | ₩16.67 Billion | ▼ -1.2 pp |
| 2024 | 97.0% | ₩385.13 Billion | ₩396.88 Billion | ₩11.75 Billion | ▲ +5.7 pp |
| 2023 | 91.3% | ₩382.75 Billion | ₩419.19 Billion | ₩36.44 Billion | ▲ +1.2 pp |
| 2022 | 90.1% | ₩445.57 Billion | ₩494.42 Billion | ₩48.85 Billion | ▼ -3.0 pp |
| 2021 | 93.1% | ₩345.91 Billion | ₩371.38 Billion | ₩25.47 Billion | ▼ -0.5 pp |
| 2020 | 93.6% | ₩347.48 Billion | ₩371.22 Billion | ₩23.75 Billion | ▲ +0.1 pp |
| 2019 | 93.5% | ₩345.49 Billion | ₩369.52 Billion | ₩24.03 Billion | ▲ +0.1 pp |
| 2018 | 93.4% | ₩324.34 Billion | ₩347.26 Billion | ₩22.93 Billion | ▲ +0.5 pp |
| 2017 | 92.9% | ₩322.83 Billion | ₩347.46 Billion | ₩24.64 Billion | ▼ -1.7 pp |
| 2016 | 94.6% | ₩320.10 Billion | ₩338.50 Billion | ₩18.40 Billion | ▲ +7.8 pp |
| 2015 | 86.7% | ₩318.34 Billion | ₩367.03 Billion | ₩48.69 Billion | ▼ -0.1 pp |
| 2014 | 86.9% | ₩328.68 Billion | ₩378.37 Billion | ₩49.69 Billion | ▲ +0.3 pp |
| 2013 | 86.6% | ₩322.74 Billion | ₩372.66 Billion | ₩49.92 Billion | — |